Diagnostic value of HepPar1, pCEA, CD10, and CD34 expression in separating hepatocellular carcinoma from metastatic carcinoma in fine‐needle aspiration cytology
暂无分享,去创建一个
Todd M Luckasevic | J. Silverman | R. Saad | Reda S Saad | Jan F Silverman | Yulin L Liu | Christine M Noga | Douglas R Johnson | Yulin L. Liu | Douglas R. E. Johnson | Todd M. Luckasevic | Christine M. Noga
[1] W. Coleman,et al. Hepatocyte paraffin 1: a monoclonal antibody that reacts with hepatocytes and can be used for differential diagnosis of hepatic tumors. , 1993, The American journal of pathology.
[2] N. Ron,et al. Use of CD34 and Factor VIII To Diagnose Hepatocellular Carcinoma on Fine Needle Aspirates , 1998, Acta Cytologica.
[3] D. Gardiol,et al. Immunohistochemistry in the Differential Diagnosis of Liver Carcinomas , 1991, The American journal of surgical pathology.
[4] M. Bibbo,et al. Diagnostic utility of Glut‐1 and CA 15‐3 in discriminating adenocarcinoma from hepatocellular carcinoma in liver tumors biopsied by fine‐needle aspiration , 2002, Cancer.
[5] M. Bibbo,et al. Diagnostic value of hepatocyte paraffin 1 antibody to discriminate hepatocellular carcinoma from metastatic carcinoma in fine‐needle aspiration biopsies of the liver , 2001, Cancer.
[6] P. Scheuer,et al. An immunohistochemical study of the blood vessels within primary hepatocellular tumours. , 2008, Liver.
[7] H. Honda,et al. CD34 expression in endothelial cells of small hepatocellular carcinoma: Its correlation with tumour progression and angiographic findings , 1995, Journal of gastroenterology and hepatology.
[8] P. Ruck,et al. Immunoreactivity of sinusoids in hepatocellular carcinoma. An immunohistochemical study using lectin UEA-1 and antibodies against endothelial markers, including CD34. , 1995, Archives of pathology & laboratory medicine.
[9] H. Hano,et al. Enhanced CD34 expression of sinusaid‐like vascular endothelial cells in hepatocellular carcinoma , 1996, Pathology international.
[10] A. Roessner,et al. Canalicular Immunostaining of Neprilysin (CD10) as a Diagnostic Marker for Hepatocellular Carcinomas , 2001, The American journal of surgical pathology.
[11] G. Sterrett,et al. Can CD34 discriminate between benign and malignant hepatocytic lesions in fine‐needle aspirates and thin core biopsies? , 2000, Cancer.
[12] F. Tan,et al. Increased expression of neprilysin (neutral endopeptidase 24.11) in rat and human hepatocellular carcinomas. , 1994, Laboratory investigation; a journal of technical methods and pathology.
[13] J. Rodríguez-Peralto,et al. Fine Needle Aspiration Cytology of Metastatic Hepatic Adrenocortical Carcinoma Mimicking Hepatocellular Carcinoma , 2001, Acta Cytologica.
[14] L. Ma,et al. Localisation of CD10 to biliary canaliculi by immunoelectron microscopical examination. , 1990, Journal of clinical pathology.
[15] L. Terracciano,et al. Hepatoid Adenocarcinoma With Liver Metastasis Mimicking Hepatocellular Carcinoma: An Immunohistochemical and Molecular Study of Eight Cases , 2003, The American journal of surgical pathology.
[16] R. Sormunen,et al. Hep Par 1 and selected antibodies in the immunohistological distinction of hepatocellular carcinoma from cholangiocarcinoma, combined tumours and metastatic carcinoma , 1998, Histopathology.
[17] J. Boitnott,et al. Immunoperoxidase staining as a diagnostic aid for hepatocellular carcinoma. , 1989, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[18] R. Ashfaq,et al. Diagnostic utility of the HepPar1 antibody to differentiate hepatocellular carcinoma from metastatic carcinoma in fine‐needle aspiration samples , 2002, Cancer.
[19] Prabodh K. Gupta,et al. Differential diagnostic dilemmas in malignant fine‐needle aspirates of liver: A practical approach to final diagnosis , 1995, Diagnostic cytopathology.
[20] M. Rijn,et al. Hep Par 1 Antibody Stain for the Differential Diagnosis of Hepatocellular Carcinoma: 676 Tumors Tested Using Tissue Microarrays and Conventional Tissue Sections , 2003, Modern Pathology.
[21] K. Shiraki,et al. High expression of CD34-positive sinusoidal endothelial cells is a risk factor for hepatocellular carcinoma in patients with HCV-associated chronic liver diseases. , 2001, Human pathology.
[22] Randall G. Lee,et al. Utilization of hepatocyte-specific antibody in the immunocytochemical evaluation of liver tumors. , 1997, Modern pathology : an official journal of the United States and Canadian Academy of Pathology, Inc.
[23] C. Morrison,et al. A Comparison of CD10 to pCEA, MOC-31, and Hepatocyte for the Distinction of Malignant Tumors in the Liver , 2002, Modern Pathology.
[24] L. Hersh,et al. Common acute lymphoblastic leukemia antigen (CALLA) is active neutral endopeptidase 24.11 ("enkephalinase"): direct evidence by cDNA transfection analysis. , 1989, Proceedings of the National Academy of Sciences of the United States of America.
[25] T. Yoshiki,et al. Gastrointestinal hepatoid adenocarcinoma: venous permeation and mimicry of hepatocellular carcinoma, a report of four cases , 1997, Histopathology.
[26] R. Bhan,et al. Spindling artefact of urothelial cells , 1995, Diagnostic cytopathology.
[27] P. Watson,et al. NCL-CD10-270: a new monoclonal antibody recognizing CD10 in paraffin-embedded tissue. , 1999, The American journal of pathology.
[28] P. Chu,et al. Paraffin-section detection of CD10 in 505 nonhematopoietic neoplasms. Frequent expression in renal cell carcinoma and endometrial stromal sarcoma. , 2000, American journal of clinical pathology.
[29] K. Ishak,et al. Clear Cell Carcinoma of the Liver: A Comparative Immunohistochemical Study with Renal Clear Cell Carcinoma , 2000, Modern Pathology.
[30] R. P. Becker,et al. Detection of neutral endopeptidase 24.11 (neprilysin) in human hepatocellular carcinomas by immunocytochemistry. , 1997, Anticancer research.
[31] S. Xiao,et al. cDNA arrays and immunohistochemistry identification of CD10/CALLA expression in hepatocellular carcinoma. , 2001, The American journal of pathology.
[32] M. Fiorentino,et al. Histogenesis of primary liver carcinomas: strengths and weaknesses of cytokeratin profile and albumin mRNA detection. , 1996, Human pathology.
[33] Y. N. Park,et al. Neoangiogenesis and sinusoidal "capillarization" in dysplastic nodules of the liver. , 1998, The American journal of surgical pathology.
[34] A. Maitra,et al. Immunoreactivity for hepatocyte paraffin 1 antibody in hepatoid adenocarcinomas of the gastrointestinal tract. , 2001, American journal of clinical pathology.
[35] H. Frierson,et al. Comparative immunohistochemical study of primary and metastatic carcinomas of the liver. , 1993, American journal of clinical pathology.
[36] H. Lazarus,et al. A monoclonal antibody to human acute lymphoblastic leukaemia antigen , 1980, Nature.
[37] S. Kakar,et al. Immunoreactivity of Hep Par 1 in hepatic and extrahepatic tumors and its correlation with albumin in situ hybridization in hepatocellular carcinoma. , 2003, American journal of clinical pathology.
[38] P. Chu,et al. Hepatocyte Antigen as a Marker of Hepatocellular Carcinoma: An Immunohistochemical Comparison to Carcinoembryonic Antigen, CD10, and Alpha-Fetoprotein , 2002, The American journal of surgical pathology.